Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: A preliminary investigation

Frontiers in Psychiatry

Volumn 3, Issue AUG, 2012, Pages

  Schmitz, Joy M ^a   Rathnayaka, Nuvan ^a   Green, Charles E ^b   Moeller, F Gerard ^a   Dougherty, Anne E ^b   Grabowski, John ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Clinical trial; Cocaine dependence; D amphetamine; Modafinil

Indexed keywords

DEXAMPHETAMINE; MODAFINIL; PLACEBO;

ADULT; ANXIETY; ARTICLE; COCAINE DEPENDENCE; CONSTIPATION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ENERGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL CONCENTRATION; MIGRAINE; PATIENT COMPLIANCE; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SIDE EFFECT; SLEEP PATTERN; THORAX PAIN; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84866881391     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00077     Document Type: Article

References (31)

1. Anderson, A. L., Reid, M. S., Li, S. H., Holmes, T., Shemanski, L., Slee, A., Smith, E. V., Kahn, R., Chiang, N., Vocci, F., Ciraulo, D., Dackis, C., Roache, J. D., Salloum, I. M., Somoza, E., Urschel, H. C. III, and Elkashef, A. M. (2009). Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 104, 133-139.
2. Bayarri, M. J., and Berger, J. O. (2004). The interplay of bayesian and frequentist analysis. Stat. Sci. 19, 58-80.
3. Businelle, M. S., Rash, C. J., Burke, R. S., and Parker, J. D. (2009). Using vouchers to increase continuing care participation in veterans: does magnitude matter? Am. J. Addict. 18, 122-129.
4. Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., and Rounsaville, B. J. (2004). Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch. Gen. Psychiatry 61, 264-272.
5. Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., and O'Brien, C. P. (2005). A double-blind, placebo-controlledtrialof modafinil for cocaine dependence. Neuropsy-chopharmacology 30, 205-211.
6. Del Boca, F. K., Kranzler, H. R., Brown, J., and Korner, P. F. (1996). Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol. Clin. Exp. Res. 20, 1412-1417.
7. Elkashef, A., and Vocci, F. (2003). Biological markers of cocaine addiction: implications for medications development. Addict. Biol. 8, 123-139.
8. Ferraro, L., Tanganelli, S., O'Connor, W. T., Antonelli, T., Rambert, F., and Fuxe, K. (1996). The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur. J. Pharmacol. 306, 33-39.
9. Grabowski, J., Rhoades, H., Schmitz, J., Stotts,A., Daruzska,L.A.,Creson, D., and Moeller,F.G..(2001).Dextroam-phetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J. Clin. Psychophar-macol. 21, 522-526.
10. Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., and Schmitz, J. (2004). Agonistlike or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials. Neuropsychopharmacology 29, 969-981.
11. Grabowski, J., Roache, J. D., Schmitz, J. M., Rhoades, H., Creson, D., and Korszun, A. (1997). Replacement medication for cocaine dependence: methylphenidate. J. Clin. Psy-chopharmacol. 17, 485-488.
12. Green, C. E., Moeller, F. G., Schmitz, J. M., Lucke, J. F., Lane, S. D., Swann, A. C., Lasky, R. E., and Carbonari, J. P. (2009). Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach. Am. J. Drug Alcohol Abuse 35, 95-102.
13. Gurrin, L. C., Kurinczuk, J. J., and Burton, P. R. (2000). Bayesian statistics in medical research: an intuitive alternative to conventional data analysis. J. Eval. Clin. Pract. 6, 193-204.
14. Herin,D.V.,Rush,C.R.,and Grabowski, J. (2010). Agonist-like pharma-cotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann. N. Y. Acad. Sci. 1187, 76-100.
15. Longo, M., Wickes, W., Smout, M., Harrison, S., Cahill, S., and White, J. M. (2010). Randomized controlled trial of dexamphetamine maintenance for the treatment of metham-phetamine dependence. Addiction 105, 146-154.
16. Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T. J., Bonab, A. A., Miller, G. M., and Fischman,A. J. (2006). Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp. Ther. 319, 561-569.
17. Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S. H., and Bridge, P. (1995). A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend. 40, 125-131.
18. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H., and Argeriou, M. (1992). The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 9, 199-213.
19. Moeller, F. G., Schmitz, J. M., Herin, D., and Kjome,K.L. (2008).Useofstim-ulants to treat cocaine and metham-phetamine abuse. Curr. Psychiatry Rep. 10, 385-391.
20. Mooney, M. E., Herin, D. V., Schmitz, J. M., Moukaddam, N., Green, C. E., and Grabowski, J. (2009). Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 101, 34-41.
21. Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance-Katz, E. F., Frankforter, T., and Rounsaville, B. J. (2000). Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. Addiction 95, 219-228.
22. Poling, J., Oliveto, A., Petry, N., Sofuoglu, M., Gonsai, K., Gonzalez, G., Martell, B., and Kosten, T. R. (2006). Six-month trial of bupropion with contingency management for cocaine dependenceina methadone-maintained population. Arch. Gen. Psychiatry 63, 219-228.
23. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., and Partilla, J. S. (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39, 32-41.
24. Sayre, S. L., Evans, M., Hokanson, P. S., Schmitz, J. M., Stotts, A. L., Averill, P., and Grabowski, J. (2004). " Who gets in?" Recruitment and screening processes of outpatient substance abuse trials. Addict. Behav. 29, 389-398.
25. Schmitz, J. M., Lindsay, J. A., Stotts, A. L., Green, C. E., and Moeller, F. G. (2010). Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets. Exp. Clin. Psychopharmacol. 18, 238-244.
26. Schmitz, J. M., Mooney, M. E., Moeller, F. G., Stotts, A. L., Green, C., and Grabowski, J. (2008). Lev-odopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. Drug Alcohol Depend. 94, 142-150.
27. Schmitz, J. M., Stotts, A. L., Rhoades, H. M., and Grabowski, J. (2001). Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict. Behav. 26, 167-180.
28. Shearer, J. (2008). The principles of agonist pharmacotherapy for psychos-timulant dependence. Drug Alcohol Rev. 27, 301-308.
29. Shearer, J., Wodak, A., van Beek, I., Mattick, R. P., and Lewis, J. (2003). Pilot randomized double blind placebo-controlled study of dexamphetamine forcocaine dependence. Addiction 98, 1137-1141.
30. Spitzer, R. L., and First, M. B. (2005). Classification of psychiatric disorders. JAMA 294, 1898-1899; author reply 1899-1900.
31. Stout,R. L.,Wirtz,P. W., Carbonari, J. P., and Del Boca, F. K. (1994). Ensuring balanced distribution of prognostic factors in treatment outcome research. J. Stud. Alcohol Suppl. 12, 70-75